Article info
PDFClinical and epidemiological research
Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry
- Correspondence to Lykke Midtbøll Ørnbjerg, DANBIO, Copenhagen University Hospital Glostrup, Department of Rheumatology, Nordre Ringvej 57, 2600 Glostrup, Denmark; lykke{at}oernbjerg.dk
Citation
Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry
Publication history
- Accepted March 8, 2012
- First published April 24, 2012.
Online issue publication
December 29, 2022
Article Versions
- Previous version (29 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions